Industry News

01/05/2023

ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics

Phase 1/2 clinical trial of ZB131 to begin enrolling expansion cohorts in early 2023 CHARLOTTESVILLE, Va., /PRNewswire/ — ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer through its innovative drug discovery platform, has appointed Alan S. Bash as the company’s new Chief Executive Officer and member of the company’s Board of Directors. The appointment of

12/15/2022

More lab space is being built in Blacksburg and Roanoke. Here’s how that can accelerate growth of the life sciences sector

Some start-ups can’t afford to build their own lab space or may only need lab space intermittently. Advocates believe that new lab space in Blacksburg and Roanoke will encourage economic development and entrepreneurship in the region. (Cardinal News, December 15, 2022) — The founders of Fermi Energy have an idea which, if it pans out,

11/16/2022

Richmond-area-based pharma company Indivior buys NARCAN developer Opiant, aims to launch new overdose reversal agent

Richmond, VA, (Richmond Times Dispatch) – Chesterfield-based Indivior, already in the business of opioid addiction treatment, is branching into overdose protection. The global pharmaceutical company entered into an agreement to acquire Opiant Pharmaceuticals Inc. for a reported $145 million. Indivior is the company best known for producing Suboxone, a commonly used medication in treating opioid addiction.

10/14/2022

BIO Announces Appointment of Interim CEO

Established Industry Leader Rachel King will Serve as BIO’s Interim Leader WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO. King’s appointment follows Dr. Michelle

08/29/2022

VIPC’s CCF Announces $1.75M In Funding to Support Virginia Startups Technology Testing and Market Validation

The Virginia Innovation Partnership Corporation (VIPC) announced new grant funding totaling approximately $1.75 million to 24 Virginia small businesses through its Commonwealth Commercialization Fund (CCF). CCF is a competitive program that seeks to fund high-potential, Virginia-based, for-profit technology companies at the pre-seed stage of commercialization and provides grants up to $75,000. Each award is matched

08/15/2022

Registration Now Open for Catalyst Life Sciences Conference

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), announced that registration is open for the Catalyst Life Sciences Conference. The event will be held October 6-7, 2022 at the Omni Hotel in  Richmond, Virginia. This conference is designed for scientists, engineers, entrepreneurs, incubators and biohubs, life science companies, technology transfer